The question is not whether AI will transform healthcare; it’s whether regulators can keep pace with that transformation.

Carthera, developer of the revolutionary SonoCloud® medical device, today announces it has enrolled the first 100 patients in ...

New findings published today in NEJM Evidence reveal promising clinical outcome for Cellenkos Inc.'s cryopreserved, allogeneic, T regulatory (Treg) cells derived from umbilical cord blood, for the ...

Perfuze, a leader in next-generation catheter-based technology for the treatment of acute ischemic stroke, today announced two significant milestones in its mission to improve stroke care: 1) the ...

The treatment of the first patient in our ELITE-BTK pivotal trial by distinguished vascular surgeon and researcher Dr. Brian DeRubertis is a significant milestone as we commence our effort to fully ...

In 2022, two 1726-nm lasers delivering energy specific to the sebaceous gland were cleared by the FDA for the treatment of ...

This would be the second application for a regenerative medical product using iPS ... their medications had decreased. The clinical trial studied the safety of the treatment on all seven patients ...

Phoenix ED device is the first at-home use acoustic wave device that helps in the treatment of erectile dysfunction. The ...

Surmodics, Inc. announced the publication of results from the TRANSCEND clinical trial. The global randomized study demonstrat ...

U.S. medical centers are seeking FDA authorization for the compassionate use — or expanded access — of Namodenoson for ...

Visually impaired patients were found to be at greater risk from medicines and medical devices which were not made safe or ...

Thanks to healthcare reform, the hurdles to securing reimbursement and technology add-on payments have risen. Boston will need to invest more in clinical studies to demonstrate superiority of outcomes ...